Joseph Edelman's Net Worth
Estimate Recalculated Oct 8, 2025 08:31PM EST
Who is Joseph Edelman
Joseph Edelman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CARGO Therapeutics, Inc., VBI VACCINES INC., ZOGENIX, INC., Prometheus Biosciences, Inc., BIOSANTE PHARMACEUTICALS INC, Crinetics Pharmaceuticals, Inc., ALBIREO PHARMA, INC., Nautilus Biotechnology, Inc., Aldeyra Therapeutics, Inc., ANTARES PHARMA INC, Athira Pharma, Inc., Verrica Pharmaceuticals Inc., LianBio, MeiraGTx Holdings plc, ARYA Sciences Acquisition Corp IV, ARYA Sciences Acquisition Corp V, ADMA BIOLOGICS, INC., AMICUS THERAPEUTICS INC, Global Blood Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., Kadmon Holdings, Inc., Menlo Therapeutics Inc., AGILE THERAPEUTICS INC, Solid Biosciences Inc., IsoPlexis Corp, XTL BIOPHARMACEUTICALS LTD, Lyra Therapeutics, Inc., Landos Biopharma, Inc., Motus GI Holdings, Inc., VBI Vaccines Inc/BC, Corium International, Inc., Astria Therapeutics, Inc., SCYNEXIS INC, LEAP THERAPEUTICS, INC., Rain Therapeutics Inc., Quotient Ltd, Athenex, Inc., LA JOLLA PHARMACEUTICAL CO, Versartis, Inc., ACELRX PHARMACEUTICALS INC, Dova Pharmaceuticals, Inc., CHEMBIO DIAGNOSTICS, INC., SOLENO THERAPEUTICS INC, REPROS THERAPEUTICS INC., TRIMERIS INC, Acrivon Therapeutics, Inc., OPTIMER PHARMACEUTICALS INC, ARYA SCIENCES ACQUISITION CORP., Aegerion Pharmaceuticals, Inc., Foamix Pharmaceuticals Ltd., MIRAVANT MEDICAL TECHNOLOGIES, INDEVUS PHARMACEUTICALS INC, BIOENVISION INC, MACROCHEM CORP, PENWEST PHARMACEUTICALS CO, PALATIN TECHNOLOGIES INC, CYPRESS BIOSCIENCE INC, Perceptive Capital Solutions Corp, VAPOTHERM INC, Orchestra BioMed Holdings, Inc., and Aja Holdco, Inc..
SEC CIK
Joseph Edelman's CIK is 0001164426
Past Insider Trading and Trends
2004 was Joseph Edelman's most active year for acquiring shares with 4 total transactions. Joseph Edelman's most active month to acquire stocks was the month of April. 2004 was Joseph Edelman's most active year for disposing of shares, totalling 3 transactions. Joseph Edelman's most active month to dispose stocks was the month of May. 2005 saw Joseph Edelman paying a total of $2,031,047.50 for 300,480 shares, this is the most they've acquired in one year. In 2004 Joseph Edelman cashed out on 14,134 shares for a total of $30,494.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
